Endo International competitors and similar companiesClear all

Endo International's competitors and similar companies include Hikma Pharmaceuticals, Teva, Takeda and KRKA.
Endo International
Endo International
Endo International plc is global specialty healthcare company. It was created as a result of a management buyout from DuPont Merck in 1997.
Hikma Pharmaceuticals
Hikma Pharmaceuticals
Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products.
Teva
Teva
Teva is a pharmaceuticals company.
Takeda
Takeda
Takeda is a biopharmaceutical company that provides healthcare solutions.
KRKA
KRKA
KRKA is an international generic pharmaceutical company.
Founding Date
Founding Date
1997
Founding Date
1978
Founding Date
1901
Founding Date
1995
Founding Date
1954
Type
Type
Public
Type
Public
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Dublin 4, IE HQ
Ciudad De México, MX
Midrand, ZA
Watford, GB
Charlotte, US
Charlotte, US
Chestnut Ridge, US
see more
Locations
London, GB HQ
Staoueli, DZ
Mississauga, CA
Boulogne Billancourt, FR
Martinsried, DE
Pavia, IT
Amman, JO
see more
Locations
HQ
Locations
Opfikon, CH HQ
Chuo City, JP
Fujisawa, JP
Hikari, JP
Kyoto, JP
Osaka, JP
Osaka, JP
Locations
SI HQ
Employees
Employees
3,1729% increase
Employees
8,700
Employees
25,286
Employees
34,826
Employees
11,6181% increase
Valuation ($)
Valuation ($)
68.4 m
Valuation ($)
4.8 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Twitter followers
Twitter followers
939
Twitter followers
2.6 k
Twitter followers
5.2 k
Twitter followers
28.4 k
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
372460
Alexa Website Rank
230430
Alexa Website Rank
626179
Alexa Website Rank
N/A
Alexa Website Rank
231469
Employee Rating
Employee Rating
3.8
Employee Rating
3.7
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
3

Financial

Revenue (est.)
Revenue (est.)
$3b (FY, 2021)
Revenue (est.)
$2.6b (FY, 2021)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
€1.6b (FY, 2021)
Cost of goods
Cost of goods
$6.2m (FY, 2021)
Cost of goods
$1.1b (FY, 2021)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
€565.8m (FY, 2021)
Gross profit
Gross profit
$3b (FY, 2021)
Gross profit
$1.5b (FY, 2021)
Gross profit
N/A
Gross profit
N/A
Gross profit
€1b (FY, 2021)
Net income
Net income
($569.1m) (FY, 2021)
Net income
$420m (FY, 2021)
Net income
N/A
Net income
N/A
Net income
€308.2m (FY, 2021)
For sources of this data, please see the company profile

View company profiles

Hikma Pharmaceuticals
HQ
London, GB
Employees
8,700

Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products.

View company
Teva
HQ
Employees
25,286

Teva is a pharmaceuticals company.

View company
Takeda
HQ
Opfikon, CH
Employees
34,826

Takeda is a biopharmaceutical company that provides healthcare solutions.

View company
KRKA
HQ
SI
Employees
11,618↑ 1% increase

KRKA is an international generic pharmaceutical company.

View company